Dr. Gaba is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
820 4th St N
Fargo, ND 58102Phone+1 701-234-6161Fax+1 701-234-7257
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2001 - 2004
Good Samaritan Hospital of MarylandResidency, Internal Medicine, 1998 - 2001
Christian Medical College VelloreClass of 1990
Certifications & Licensure
ND State Medical License 2004 - 2026
MN State Medical License 2005 - 2025
VA State Medical License 2002 - 2008- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer Start of enrollment: 2016 Mar 14
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 35 citationsPalbociclib in Patients With Non–Small-Cell Lung Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry StudyEugene R Ahn, Pam K. Mangat, Elizabeth Garrett-Mayer, Susan Halabi, Elie G. Dib
JCO Precision Oncology. 2020-06-25 - 61 citationsPhase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancer.Missak Haigentz, Mimi Kim, Catherine Sarta, Juan Lin, Roger Keresztes
Oral Oncology. 2012-12-01 - 6 citationsPertuzumab Plus Trastuzumab in Patients With Lung Cancer WithMutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study.Apar K Ganti, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Elie G Dib
JCO Precision Oncology. 2023-06-01
Press Mentions
Genetic Changes Are Focus of Sanford Breast Cancer Clinical TrialOctober 29th, 2015
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
